JP2021511351A5 - - Google Patents

Info

Publication number
JP2021511351A5
JP2021511351A5 JP2020540565A JP2020540565A JP2021511351A5 JP 2021511351 A5 JP2021511351 A5 JP 2021511351A5 JP 2020540565 A JP2020540565 A JP 2020540565A JP 2020540565 A JP2020540565 A JP 2020540565A JP 2021511351 A5 JP2021511351 A5 JP 2021511351A5
Authority
JP
Japan
Prior art keywords
diazaspiro
cyclopropane
bicyclo
octane
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020540565A
Other languages
English (en)
Japanese (ja)
Other versions
JP7273420B2 (ja
JP2021511351A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2019/073000 external-priority patent/WO2019144912A1/zh
Publication of JP2021511351A publication Critical patent/JP2021511351A/ja
Publication of JP2021511351A5 publication Critical patent/JP2021511351A5/ja
Application granted granted Critical
Publication of JP7273420B2 publication Critical patent/JP7273420B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020540565A 2018-01-25 2019-01-24 β-ラクタマーゼ阻害剤及びその用途 Active JP7273420B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2018074185 2018-01-25
CNPCT/CN2018/074185 2018-01-25
PCT/CN2019/073000 WO2019144912A1 (zh) 2018-01-25 2019-01-24 β-内酰胺酶抑制剂及其用途

Publications (3)

Publication Number Publication Date
JP2021511351A JP2021511351A (ja) 2021-05-06
JP2021511351A5 true JP2021511351A5 (https=) 2023-03-13
JP7273420B2 JP7273420B2 (ja) 2023-05-15

Family

ID=67394549

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020540565A Active JP7273420B2 (ja) 2018-01-25 2019-01-24 β-ラクタマーゼ阻害剤及びその用途

Country Status (8)

Country Link
US (1) US11078202B2 (https=)
EP (1) EP3744722A4 (https=)
JP (1) JP7273420B2 (https=)
KR (1) KR102769880B1 (https=)
CN (1) CN111670187B (https=)
AU (1) AU2019211693B2 (https=)
CA (1) CA3089150A1 (https=)
WO (1) WO2019144912A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102769880B1 (ko) 2018-01-25 2025-02-20 쑤저우 시노벤트 파마슈티칼즈 씨오., 엘티디. β-락타마제 억제제 및 그 용도
CA3238268A1 (en) 2021-11-17 2023-05-25 Xufan WANG ?-lactamase inhibitor intermediate and preparation method therefor
CN117186107A (zh) * 2022-05-31 2023-12-08 成都先导药物开发股份有限公司 一种制备2-取代-5,7-二羰基-2,6-二氮杂螺[3,4]辛烷中间体的方法
EP4659750A1 (en) 2023-02-02 2025-12-10 Evopoint Biosciences Co., Ltd. PHARMACEUTICAL COMPOSITION CONTAINING ß-LACTAMASE INHIBITOR AND USE THEREOF
CN116730941B (zh) * 2023-06-15 2024-07-02 广东省科学院微生物研究所(广东省微生物分析检测中心) 5-苯基-1,3,4-恶二唑类化合物及其制备方法和应用
CN118453513B (zh) * 2024-05-23 2025-06-17 苏州信诺维医药科技股份有限公司 一种β-内酰胺酶抑制剂液体制剂的制备工艺

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1098129A (en) 1910-04-05 1914-05-26 John Thomas Simpson Aeroplane.
US1033000A (en) 1910-12-14 1912-07-16 Joseph Leslie Forster Pneumatic piano-player.
US1337809A (en) 1917-06-22 1920-04-20 Winton Alexander Protecting means for vessels
ES2533826T3 (es) * 2008-01-18 2015-04-15 Merck Sharp & Dohme Corp. Inhibidores de beta-lactamasa
MX340533B (es) * 2011-08-30 2016-07-13 Wockhardt Ltd Derivados de 1,6- diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas.
TW201343645A (zh) 2012-03-30 2013-11-01 Cubist Pharm Inc 1,3,4-□二唑及1,3,4-噻二唑β-內醯胺酶抑制劑
KR20150003777A (ko) * 2012-03-30 2015-01-09 큐비스트 파마슈티컬즈 인코포레이티드 이속사졸 β-락타마제 억제제
WO2014141132A1 (en) * 2013-03-14 2014-09-18 Naeja Pharmaceutical Inc. NEW HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS
US9822115B2 (en) 2014-01-21 2017-11-21 Wockhardt Limited Nitrogen containing compounds and their use as antibacterial agents
IN2014MU01196A (https=) * 2014-03-29 2015-10-02 Wockhardt Ltd
EP3131583A1 (en) 2014-04-18 2017-02-22 The Wockhardt Limited Pharmaceutical compositions comprising antibacterial agents
WO2015173663A1 (en) 2014-05-14 2015-11-19 Wockhardt Limited A process for preparation of trans-sulfuric acid mono-{2-[5-(2-methylamino-ethyl)-[1,3,4]-oxadiazol-2-yl]-7-oxo-1,6-diaza-bicyclo [3.2.1]oct-6-yl} ester
WO2015173665A1 (en) 2014-05-14 2015-11-19 Wockhardt Limited A process for preparation of trans-sulfuric acid mono-{2-[5-(3-azetidinylamino)-methyl-[1,3,4]- oxadiazol-2-yl]-7-oxo-1,6-diazabicyclo[3.2.1] oct-6-yl} ester trifluoroacetate
CA3000087A1 (en) 2015-10-02 2017-04-06 Legochem Biosciences, Inc. Compositions and methods for inhibiting beta-lactamase
KR102769880B1 (ko) 2018-01-25 2025-02-20 쑤저우 시노벤트 파마슈티칼즈 씨오., 엘티디. β-락타마제 억제제 및 그 용도

Similar Documents

Publication Publication Date Title
JP2021511351A5 (https=)
US7582659B2 (en) Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
CN111670187A (zh) β-内酰胺酶抑制剂及其用途
US8754102B2 (en) Nitrogen containing compounds and their use
CN103649088B (zh) 1, 6- 二氮杂双环[3, 2, 1]辛- 7- 酮衍生物及其在治疗细菌感染中的用途
SI2182950T1 (en) Use of 4- (pyrrolidin-1-yl) quinoline compounds for killing clinically latent microorganisms
US20070185132A1 (en) Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereo
US10273235B2 (en) Compositions and methods for inhibiting β-lactamase
CA2489411A1 (en) Difluorothioacetamides of oxazolidinones as antibacterial agents
AU2004256084B2 (en) Oxazolidinone antibiotics and derivatives thereof
TW382625B (en) Cis-substituted fluoromethylpyrrolidine derivative
US20040102494A1 (en) Novel heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them
JP2007521284A (ja) オキサゾリジノン系抗生物質及びその誘導体
US20070004712A1 (en) Salts of novel heterocyclic compounds having antibacterial activity
US20040072842A1 (en) Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent